D. de Korte

849 total citations
25 papers, 716 citations indexed

About

D. de Korte is a scholar working on Biochemistry, Hematology and Management of Technology and Innovation. According to data from OpenAlex, D. de Korte has authored 25 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biochemistry, 10 papers in Hematology and 8 papers in Management of Technology and Innovation. Recurrent topics in D. de Korte's work include Blood transfusion and management (13 papers), Platelet Disorders and Treatments (8 papers) and Blood donation and transfusion practices (8 papers). D. de Korte is often cited by papers focused on Blood transfusion and management (13 papers), Platelet Disorders and Treatments (8 papers) and Blood donation and transfusion practices (8 papers). D. de Korte collaborates with scholars based in Netherlands, United States and United Kingdom. D. de Korte's co-authors include C.W.N. Gouwerok, Rob Fijnheer, R. N. I. Pietersz, Hendrik W. Reesink, W.J.A. Dekker, Joost C.B.M. Zomerdijk, Piet Borst, E.H. Kostelijk, Peter W. Laird and Dirk Roos and has published in prestigious journals such as The EMBO Journal, Biochemistry and Thrombosis and Haemostasis.

In The Last Decade

D. de Korte

25 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. de Korte Netherlands	14	357	342	170	100	94	25	716
Nahreen Tynngård Sweden	16	199 0.6×	333 1.0×	83 0.5×	45 0.5×	62 0.7×	33	660
Robbie K. Montgomery United States	17	552 1.5×	325 1.0×	286 1.7×	51 0.5×	84 0.9×	33	1.0k
Pranee Krailadsiri United Kingdom	17	401 1.1×	413 1.2×	256 1.5×	40 0.4×	68 0.7×	47	692
W.J.A. Dekker Netherlands	13	505 1.4×	437 1.3×	328 1.9×	22 0.2×	23 0.2×	19	745
R Carmen United States	12	350 1.0×	246 0.7×	156 0.9×	44 0.4×	19 0.2×	16	610
Lacey Johnson Australia	24	946 2.6×	761 2.2×	536 3.2×	15 0.1×	104 1.1×	72	1.4k
Ehteramolsadat Hosseini Iran	17	106 0.3×	360 1.1×	17 0.1×	81 0.8×	116 1.2×	46	848
Magali J. Fontaine United States	12	154 0.4×	90 0.3×	111 0.7×	54 0.5×	84 0.9×	55	628
G. Rock Canada	10	110 0.3×	299 0.9×	74 0.4×	16 0.2×	13 0.1×	31	486
N. McCombie Canada	12	106 0.3×	171 0.5×	84 0.5×	21 0.2×	124 1.3×	21	399

Countries citing papers authored by D. de Korte

Since Specialization

Citations

This map shows the geographic impact of D. de Korte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. de Korte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. de Korte more than expected).

Fields of papers citing papers by D. de Korte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. de Korte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. de Korte. The network helps show where D. de Korte may publish in the future.

Co-authorship network of co-authors of D. de Korte

This figure shows the co-authorship network connecting the top 25 collaborators of D. de Korte. A scholar is included among the top collaborators of D. de Korte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. de Korte. D. de Korte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korte, D. de & Menno Hoekstra. (2025). Protein Arginine Methyltransferase 1: A Multi-Purpose Player in the Development of Cancer and Metabolic Disease. Biomolecules. 15(2). 185–185. 3 indexed citations

Korte, D. de, et al.. (2017). First Application of an Absorbable Skin Stapler in Peripheral Vascular Surgical Procedures. Zenodo (CERN European Organization for Nuclear Research). 3(1). 3 indexed citations

Korte, D. de. (2016). New additive solutions for red cells. ISBT Science Series. 11(S1). 165–170. 12 indexed citations

Vrielink, Hans, et al.. (2013). Plasmapheresis and clotting activation. Transfusion and Apheresis Science. 48(2). 157–157. 1 indexed citations

Nightingale, M. J., et al.. (2011). Eurobloodpack: a common European design for blood bag systems with integral leucodepletion filters. Vox Sanguinis. 101(3). 250–254. 3 indexed citations

Meer, Pieter F. van der, et al.. (2010). Effect of rate and delay of cooling during initial cooling process: in vitro effect on red cells. Vox Sanguinis. 101(1). 16–20. 2 indexed citations

Terpstra, Fokke G., D. de Korte, Johan W.M. Lagerberg, et al.. (2006). Differential sensitivities of pathogens in red cell concentrates to Tri‐P(4)‐photoinactivation. Vox Sanguinis. 91(2). 111–118. 22 indexed citations

Korte, D. de, et al.. (2004). Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen‐reduction technology‐treated apheresis platelet products. Vox Sanguinis. 87(2). 82–90. 67 indexed citations

Hilarius, P. M., et al.. (2004). Generation of Singlet Oxygen Induces Phospholipid Scrambling in Human Erythrocytes. Biochemistry. 43(13). 4012–4019. 12 indexed citations

10.

Besselink, G.A.J., et al.. (2003). Composition of the additive solution affects red blood cell integrity after photodynamic treatment. Vox Sanguinis. 85(3). 183–189. 15 indexed citations

11.

Besselink, G.A.J., F. A. C. van Engelenburg, Johan W.M. Lagerberg, et al.. (2002). The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected. Transfusion. 42(6). 728–733. 11 indexed citations

12.

Korte, D. de, et al.. (2001). Automated blood‐mixing devices still fail to mix at low bleeding rates. Vox Sanguinis. 80(1). 34–39. 5 indexed citations

13.

Kostelijk, E.H., Claudia C. Folman, C.W.N. Gouwerok, et al.. (2000). Increase in Glycocalicin Levels in Platelet Concentrates Stored in Plasma or Synthetic Medium for 8 Days: Comparison with Other Platelet Activation Markers. Vox Sanguinis. 79(1). 21–26. 25 indexed citations

14.

Korte, D. de, et al.. (2000). Comparison between a new PVC platelet storage container (UPX80) and a polyolefin container. Transfusion Medicine. 10(2). 131–139. 20 indexed citations

15.

Gouwerok, C.W.N., et al.. (1994). Platelets Stored for 6 Days in a Polyolefin Container in a Synthetic Medium with Minimal Plasma Carry‐Over. Vox Sanguinis. 66(1). 18–24. 20 indexed citations

16.

Gouwerok, C.W.N., et al.. (1994). In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration. Transfusion. 34(4). 311–316. 24 indexed citations

17.

Gouwerok, C.W.N., et al.. (1994). The Platelet Adhesion Capacity to Subendothelial Matrix and Collagen in a Flow Model during Storage of Platelet Concentrates for 7 Days. Thrombosis and Haemostasis. 72(4). 611–616. 24 indexed citations

18.

Fijnheer, Rob, Alfons J.M. van den Eertwegh, C.W.N. Gouwerok, et al.. (1991). In vitro Evaluation of Buffy‐Coat‐Derived Platelet Concentrates Stored in a Synthetic Medium¹. Vox Sanguinis. 60(1). 16–22. 34 indexed citations

19.

Fijnheer, Rob, R. N. I. Pietersz, D. de Korte, et al.. (1990). Platelet activation during preparation of platelet concentrates: a comparison of the platelet‐rich plasma and the buffy coat methods. Transfusion. 30(7). 634–638. 173 indexed citations

20.

Fijnheer, Rob, R. N. I. Pietersz, D. de Korte, & Dirk Roos. (1989). Monitoring of platelet morphology during storage of platelet concentrates. Transfusion. 29(1). 36–40. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact